Virginia Retirement Systems ET AL Invests $235,000 in Core Laboratories NV (CLB)
Virginia Retirement Systems ET AL purchased a new position in shares of Core Laboratories NV (NYSE:CLB) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 1,900 shares of the company’s stock, valued at approximately $235,000.
Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. MU Investments Co. Ltd. purchased a new position in shares of Core Laboratories NV during the second quarter worth approximately $115,000. CIBC World Markets Inc. purchased a new position in shares of Core Laboratories NV during the second quarter worth approximately $205,000. Creative Planning boosted its position in shares of Core Laboratories NV by 19.8% in the second quarter. Creative Planning now owns 1,814 shares of the company’s stock worth $225,000 after buying an additional 300 shares in the last quarter. Dynamic Advisors Solutions LLC boosted its position in shares of Core Laboratories NV by 5.6% in the second quarter. Dynamic Advisors Solutions LLC now owns 2,010 shares of the company’s stock worth $249,000 after buying an additional 106 shares in the last quarter. Finally, Schonfeld Strategic Advisors LLC purchased a new position in shares of Core Laboratories NV during the first quarter worth approximately $233,000.
Shares of Core Laboratories NV (NYSE:CLB) opened at 114.42 on Wednesday. The stock has a market capitalization of $5.05 billion, a PE ratio of 60.70 and a beta of 1.45. Core Laboratories NV has a one year low of $84.50 and a one year high of $135.49. The company’s 50-day moving average price is $111.04 and its 200 day moving average price is $117.55.
Core Laboratories NV (NYSE:CLB) last released its earnings results on Wednesday, July 20th. The company reported $0.35 EPS for the quarter, meeting analysts’ consensus estimates of $0.35. The firm had revenue of $148.10 million for the quarter, compared to analysts’ expectations of $146.37 million. Core Laboratories NV had a return on equity of 344.55% and a net margin of 11.81%. The company’s quarterly revenue was down 27.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.81 earnings per share. Analysts anticipate that Core Laboratories NV will post $1.54 EPS for the current year.
A number of brokerages have recently commented on CLB. Citigroup Inc. upped their price target on Core Laboratories NV from $110.00 to $115.00 and gave the company a “neutral” rating in a research report on Tuesday. DA Davidson assumed coverage on Core Laboratories NV in a research report on Wednesday, October 5th. They set a “buy” rating and a $136.00 price target on the stock. Zacks Investment Research cut Core Laboratories NV from a “buy” rating to a “hold” rating in a report on Monday, September 26th. Credit Suisse Group AG started coverage on Core Laboratories NV in a research note on Thursday, September 1st. They issued a “neutral” rating and a $115.00 target price on the stock. Finally, Loop Capital started coverage on Core Laboratories NV in a research note on Friday, September 30th. They issued a “hold” rating and a $120.00 target price on the stock. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $121.61.
About Core Laboratories NV
Core Laboratories N.V. is a provider of reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company’s services and products are directed toward enabling the Company’s clients to improve reservoir performance and increase oil and gas recovery from their producing fields.
Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories NV (NYSE:CLB).
Receive News & Ratings for Core Laboratories NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories NV and related companies with MarketBeat.com's FREE daily email newsletter.